Deletion of Ptpn2 in B cells promotes autoimmunity via TLR and JAK/STAT signaling
JCI Insight · 2025
DOI: 10.1172/jci.insight.196144 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Bridget N Alexander und 8 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 2, B-Lymphocytes, Autoimmunity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Autoimmunity arises when self-reactive B and T cells target the body’s own tissues, with B cells contributing through antigen presentation as well as production of autoantibodies and proinflammatory cytokines. Genome wide association studies (GWAS) and recent identification of loss-of-function gene variants in individuals with young-onset autoimmunity have highlighted a role for protein tyrosine phosphatase nonreceptor type 2 (PTPN2) in development of autoimmunity. While prior studies have focused on the mechanism of Ptpn2 in T cells and other cell types, its function in B cells has not been explored. To test the B cell–intrinsic roles of Ptpn2 , we generated a B cell – specific deletion of Ptpn2 in mice (Mb1-Cre; Ptpn2 fl/fl ). We found that loss of Ptpn2 in B cells promoted organ inflammation, increased the frequency of age/autoimmune-associated B cells (ABCs) and plasmablasts in the periphery, and increased circulating autoantibodies. Moreover, we found that Ptpn2 acted as a negative regulator of the JAK/STAT and TLR7 pathways in B cells. In line with this, treatment of B cells from Mb1-Cre;Ptpn2 fl/fl mice with IFN-γ and TLR7 agonist lead to enhanced differentiation into ABCs. These findings highlight the critical roles of Ptpn2 in B cell function and its potential as a key regulator in preventing B cell associated autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barbara Davis Center for Diabetes.
- Department of Immunology and Microbiology, and.
- Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- Boettcher Foundation
Zitieren
APA
Alexander, B. N., Kim, S., Wells, K. L., Hunter, M. J., Toole, K. P., Wemlinger, S. M., Regan, D. P., Getahun, A., & Smith, M. J. (2025). Deletion of Ptpn2 in B cells promotes autoimmunity via TLR and JAK/STAT signaling. JCI Insight. https://doi.org/10.1172/jci.insight.196144
Vancouver
Alexander BN, Kim S, Wells KL, Hunter MJ, Toole KP, Wemlinger SM, et al. Deletion of Ptpn2 in B cells promotes autoimmunity via TLR and JAK/STAT signaling. JCI Insight. 2025. doi:10.1172/jci.insight.196144
BibTeX
@article{Alexander2025,
author = {Alexander, Bridget N and Kim, Soojin and Wells, Kristen L and Hunter, Maya J and Toole, Kevin P and Wemlinger, Scott M and Regan, Daniel P and Getahun, Andrew and Smith, Mia J},
title = {Deletion of Ptpn2 in B cells promotes autoimmunity via TLR and JAK/STAT signaling},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.196144}
}
EUVIMED